SVS elects Joseph L Mills of Baylor College of Medicine to 2021–2022 officer lineup

1085
Joseph L Mills

The Society for Vascular Surgery (SVS) today announced its officers for 2021–2022. Several officers shifted roles and Joseph L Mills (Baylor College of Medicine, Houston, USA) was elected vice president at the SVS annual business meeting, held virtually on 16 June 2021.

SVS leaders for the upcoming year include:

  • Ali AbuRahma (West Virginia University, Charleston, USA), president
  • Michael Dalsing (Indiana University School of Medicine, Indianapolis, USA), president-elect
  • Joseph L Mills, Sr (Baylor College of Medicine, Houston, USA), vice president
  • Amy Reed (University of Minnesota Medical School, Minneapolis, USA), secretary
  • Keith Calligaro (University of Pennsylvania School of Medicine, Philadelphia, USA), treasurer
  • Ronald Dalman (Stanford University, Stanford, USA), immediate past president

Joseph L Mills is the Reid professor and chief of vascular surgery and endovascular therapy, and programme director of vascular surgery integrated residency at Baylor College of Medicine in Houston, USA. He specialises in diabetic foot amputation prevention and limb salvage. Mills has been co-editor of the prestigious “Rutherford’s Vascular Surgery” (7th, 8th, and 9th editions), the “go-to” textbook for vascular surgery. He is currently an associate editor of the European Journal of Vascular and Endovascular Surgery.

A renowned researcher, Mills has authored more than 360 peer-reviewed journal articles and book chapters, focused on his clinical and research interests in non-invasive diagnosis, vein graft stenosis, intimal hyperplasia, and limb salvage in patients with diabetes mellitus. He has been the principal investigator for over 50 clinical trials, including a number of current investigations.

“I am honoured to be elected as a leader of the SVS and hope to utilise my role to further advocate for patients and our profession,” said Mills. “Our specialty, and medicine in general, are continually changing, and I look forward to being an integral part of how the SVS responds to today’s rapidly evolving healthcare environment.”


LEAVE A REPLY

Please enter your comment!
Please enter your name here